Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...

Victoza is part of the list of GLP-1 receptors, which may help Black women address metabolic health concerns such as diabetes prevention and management. With a daily dose, you can reduce blood sugar ...

This article first appeared on GuruFocus. A class action lawsuit filed on Friday is bringing Novo Nordisk (NYSE:NVO) back into the spotlight, with allegations that its handling of competition around ...

A class action lawsuit was filed in New York federal court on Friday accusing Novo Nordisk (NVO) of running a "pay-for-delay" scheme with Teva Pharmaceutical (TEVA) to unlawfully delay the market ...

Danish pharmaceutical giant Novo Nordisk was hit with a class action lawsuit ‍in New York federal court on Friday for allegedly misusing its patents to maintain a monopoly on ‌its diabetes drug ...

Jan 23 (Reuters) - Danish pharmaceutical giant Novo Nordisk was hit with a class action lawsuit in New York federal court on Friday for allegedly misusing its patents to maintain a monopoly on its ...

Erika Prouty, PharmD, is a professional community pharmacist who aids patients in medication management and pharmacy services in North Adams, Massachusetts. Saxenda is an injection approved to help ...

Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes and reduce certain heart risks. Its mechanism of action is mimicking a natural hormone (GLP-1) that manages your blood sugar ...

Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...

The first generic version of the first-generation obesity treatment medication has been approved in the United States. The U.S. Food and Drug Administration (FDA) granted approval on the 23rd (local ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the treatment ...

The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country. Subscribe to read ...